<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.193" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">414 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 594.310 L102.350 594.310 "/>
  <g begin="text">
   <text y="74.592" x="49.606" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="77.112" x="52.531,58.03,60.532,65.032,69.532,73.528,78.028,80.278,83.275,87.775,91.771,95.767,98.017,101.014,105.514,109.51,111.76,114.01,116.26,122.263,126.763,133.261,137.761,141.262,143.764,148.264,152.764,156.76,159.01,161.26,168.757,174.256,176.506,178.756,185.254,189.754,192.256,194.758,198.754,203.254,205.504,210.004,212.506,217.006,219.508,223.504,227.005,229.255" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.33,0.5,0.44,0.25,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec Inc., Cambridge, MA, United States, </text>
   <text y="74.592" x="231.503" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">7</text>
   <text y="77.112" x="234.428,240.926,245.426,247.928,251.924,255.921,259.422,262.923,265.425,267.927,271.923" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University </text>
   <text y="88.11" x="49.605,56.103,60.603,64.104,68.604,71.106,73.608,78.108,80.61,82.86,85.11,90.609,95.109,98.61,102.606,105.108,107.358,113.361,117.357,121.857,125.358,129.858,132.36,136.86,141.36,145.356,147.606,149.856,155.355,159.855,163.356,167.352,169.854,172.104,174.354,178.854,184.857,187.359,189.861,193.362,197.358,200.859,203.361,207.861,212.361" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital, Basel Neurology, Basel, Switzerland</text>
   <text y="115.11" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.953,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="115.11" x="103.461,106.458,110.958,113.208,114.468,116.97,121.47,125.466,127.716,128.976,133.98,138.48,142.476,145.977,149.973,152.223,153.483,157.983,160.233,161.493,167.991,173.49,178.493,181.49,187.988,193.487,195.737,196.997,200.993,205.493,209.993,212.243,213.503,219.506,226.004,232.502,237.506,240.503,246.506,254.507,256.757,258.017,261.518,264.021,268.521,273.021,275.523,279.519,283.02,285.27" svgx:width="0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.25,0.55,0.72,0.61,0.56,0.33,0.72,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In the Phase 3 DEFINE and CONFIRM studies, </text>
   <text y="126.108" x="49.605,54.105,58.101,60.603,63.105,67.101,71.601,74.103,77.604,79.854,81.221,83.723,86.72,90.716,94.713,97.215,101.211,105.711,107.961,109.329,115.827,118.329,120.831,125.331,127.581,128.949,133.449,137.445,139.947,143.943,148.443,152.439,156.939,159.936,162.932,166.928,169.43,173.426,177.423,180.924,184.92,187.17,188.538,193.038,195.54,202.542,206.538,209.04,213.54,218.04,220.542,222.792,224.16,227.156,231.656,238.658,242.654,245.651,249.647,252.149,256.145,258.395,259.763,262.76,269.258,277.259,282.263,285.26" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.55,0.33,0.72,0.89,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients treated with delayed-release dimethyl fumarate (DMF) </text>
   <text y="137.106" x="49.605,53.106,57.606,62.106,68.604,72.6,77.1,79.233,83.733,87.729,90.231,92.733,96.729,99.726,101.859,106.359,110.355,114.351,116.853,119.355,123.855,126.852,129.849,133.845,136.347,140.343,142.845,146.841,151.341,153.474,157.974,162.474,166.47,168.972,171.474,173.976,178.476,180.609,185.109,188.106,190.239,192.741,195.243,198.24,202.236,204.368,207.365,213.863,219.867,226.365,230.865,236.363,239.36,241.493,245.993,250.493,254.489,257.486,259.619,264.119,266.252,270.752,274.748,278.744,281.741,285.242" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.33,0.72,0.67,0.72,0.5,0.61,0.33,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed better health-related quality of life (HRQoL) over 2 years </text>
   <text y="148.104" x="49.605,53.601,57.102,59.424,63.42,66.921,70.422,74.418,77.919,81.42,85.416,89.916,92.238,96.738,101.238,103.56,106.062,110.562,114.558,116.88,121.883,126.383,130.883,133.88,136.382,138.704,143.708,148.208,151.205,158.207,161.204,165.704,170.204,172.526,177.026,181.022,184.019,187.52,190.022,194.522,199.022,201.344,205.844,208.167,211.163,216.167,221.171,224.168,228.668,233.168,237.668,242.168,245.165,247.415,249.737,253.733,258.233,265.236,269.736,273.732,276.729,280.725,285.225" svgx:width="0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.5,0.5,0.33,0.28,0.25,0.56,0.5,0.33,0.78,0.33,0.5,0.5,0.25,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25,0.5,0.25,0.33,0.56,0.56,0.33,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">as assessed by the Short Form-36 version 1 (SF-36v1), compared </text>
   <text y="159.102" x="49.605,56.103,58.605,61.107,65.607,67.857,72.357,74.859,78.855,82.851,86.847,91.347,95.847,98.097,101.094,106.098,112.101,118.599,121.596" svgx:width="0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.33,0.56,0.67,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with placebo (PBO).</text>
   <text y="170.1" x="49.605,56.607,61.611,64.608,68.604,72.6,75.597,78.099,82.599,86.595,90.096,93.093" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="170.1" x="95.721,100.59,105.09,107.718,112.218,115.215,119.211,122.712,126.708,131.208,133.71,136.338,140.334,142.962,147.462,150.459,154.959,158.955,162.951,165.948,168.576,171.078,175.578,178.08,182.076,185.073,187.575,194.577,197.205,201.201,205.701,209.697,212.199,216.699,220.2,222.702,226.203,228.831,233.331,236.328,238.956,245.454,251.457,257.955,262.455,267.621,270.249,274.749,278.745,281.247,285.243" svgx:width="0.61,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.44,0.25,0.5,0.33,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.28,0.44,0.33,0.28,0.78,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.72,0.67,0.72,0.5,0.61,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To present a 2-year interim analysis of HRQoL data </text>
   <text y="181.098" x="49.605,52.602,55.599,60.099,67.101,69.351,71.286,76.785,83.283,89.781,96.279,102.282,107.286,112.785,115.035,117.285,119.22,123.216,127.716,129.966,131.901,136.401,140.901,145.401,149.901,152.403,156.903,161.403,163.653,165.903,167.838,172.338,175.335,179.835,183.831,187.827,190.464,192.714,194.964,196.898,201.398,205.898,209.4,213.396,216.393,220.893,223.395,225.896,230.396,234.896,237.146,239.081,243.077,247.577,250.079,254.076,258.576,262.077,264.579,269.079,273.579,275.829,277.764,282.264,285.261" svgx:width="0.33,0.33,0.5,0.78,0.25,0.55,0.61,0.72,0.72,0.72,0.67,0.56,0.61,0.25,0.25,0.55,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.33,0.25,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">from ENDORSE, an ongoing, 5-year, dose-blind extension of </text>
   <text y="192.096" x="49.605,56.103,61.602,66.606,69.603,76.101,81.6,83.85,87.846,92.346,96.846,99.096,105.099,111.597,118.095,123.099,126.096,132.099,140.1" svgx:width="0.72,0.61,0.56,0.33,0.72,0.61,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DEFINE and CONFIRM.</text>
   <text y="203.094" x="49.605,58.101,62.097,65.093,70.097,74.597,79.601,83.102,86.099" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="203.094" x="89.051,94.055,98.051,100.553,103.055,107.051,111.551,114.053,117.554,119.804,120.507,123.504,127.5,132.0,136.5,141.0,148.002,150.504,154.5,158.496,162.996,165.246,165.948,168.45,172.95,175.2,175.902,180.402,184.398,186.9,190.896,195.396,199.392,203.892,206.889,209.885,213.882,216.383,220.38,224.376,227.877,231.873,234.123,234.825,241.323,249.324,254.328,256.578,257.28,261.78,266.28,270.78,273.03,273.732,280.734,285.234" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.72,0.89,0.56,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients randomized to delayed-release DMF 240 mg </text>
   <text y="214.092" x="49.604,52.106,58.604,61.106,65.103,69.099,71.349,72.618,75.615,81.618,84.615,91.113,94.11,96.36,97.629,102.129,105.126,107.376,108.645,111.146,115.646,118.644,122.64,126.636,128.886,130.155,132.657,135.159,142.161,146.157,149.658,151.908,153.177,157.677,161.673,164.175,166.677,171.177,173.427,174.696,177.693,183.191,186.188,192.686,195.683,197.933,199.202,201.704,206.204,208.454,209.723,216.221,221.72,226.724,229.721,236.219,241.718,244.22,250.223,256.721,263.219,268.223,271.22,277.223,285.224" svgx:width="0.28,0.72,0.28,0.44,0.44,0.25,0.55,0.33,0.67,0.33,0.72,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.28,0.28,0.78,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.33,0.61,0.33,0.72,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.61,0.56,0.33,0.72,0.61,0.28,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">twice (BID) or three times daily (TID) in DEFINE/CONFIRM </text>
   <text y="225.09" x="49.604,53.6,58.1,62.6,65.103,67.604,72.104,76.604,80.601,85.101,87.657,90.159,94.659,98.655,101.211,104.712,108.708,115.71,119.706,122.262,126.762,131.262,134.763,138.759,141.315,144.312,148.308,152.808,155.31,162.312,166.308,170.808,173.364,175.866,180.366,182.922,188.421,194.919,201.417,207.915,213.918,218.922,224.421,226.671,229.227,234.23,238.227,240.729,243.23,247.227,251.727,254.229,257.729,260.285,263.283,267.279,271.275,275.271,277.773,282.273" svgx:width="0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.78,0.44,0.25,0.5,0.5,0.39,0.44,0.25,0.33,0.44,0.5,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.61,0.72,0.72,0.72,0.67,0.56,0.61,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">continued the same dose regimen in ENDORSE. Patients receiv-</text>
   <text y="236.088" x="49.604,52.106,56.606,61.106,63.356,66.309,71.313,77.315,83.813,86.063,89.016,92.013,98.511,104.01,109.014,112.011,118.509,124.008,126.51,132.513,139.011,145.509,150.513,153.51,159.513,167.514,170.511,172.761,175.713,179.709,184.209,188.709,190.959,193.911,198.411,200.913,204.909,207.411,209.913,212.91,216.906,223.908,227.904,230.9,233.15,236.102,240.098,244.094,248.09,250.592,254.589,257.091,261.087,263.337,266.28,269.277,275.775,282.272,285.27" svgx:width="0.28,0.5,0.5,0.25,0.55,0.56,0.67,0.72,0.25,0.55,0.33,0.72,0.61,0.56,0.33,0.72,0.61,0.28,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.55,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.55,0.33,0.72,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing PBO (DEFINE/CONFIRM) and glatiramer acetate (GA) </text>
   <text y="247.086" x="49.604,52.602,58.604,65.103,71.601,76.604,79.602,85.604,93.605,96.603,98.853,101.346,107.844,111.84,114.837,118.833,121.083,123.576,126.573,130.569,135.069,139.569,144.069,151.071,153.573,157.569,161.565,166.065,168.315,170.808,175.308,177.81,182.31,184.56,187.053,189.555,194.055,196.305,198.798,203.298,205.799,208.301,212.801,217.301,221.298,225.798,228.048,230.54,233.042,236.039,240.035,244.031,246.533,253.535,257.531,262.031,264.534,266.784,269.277,275.775,278.277,280.779,285.279" svgx:width="0.33,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(CONFIRM) were randomized 1:1 to blinded treatment with </text>
   <text y="258.084" x="49.604,54.104,58.1,60.602,64.598,69.098,73.094,77.594,80.591,83.589,87.585,90.087,94.083,98.079,101.58,105.576,107.421,113.919,121.92,126.924,128.769,134.772,137.769,144.267,146.112,150.612,153.609,155.292,160.79,163.787,170.285,172.535,174.218,179.717,184.217,188.213,190.058,195.062,200.066,203.063,207.563,212.063,216.563,221.063,222.908,229.406,233.402,236.903,238.748,242.744,247.244,254.246,256.749,261.249,263.751,267.252,269.754,273.75,276.747,280.743,285.243" svgx:width="0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.72,0.89,0.56,0.25,0.67,0.33,0.72,0.25,0.5,0.33,0.25,0.61,0.33,0.72,0.25,0.25,0.61,0.5,0.44,0.25,0.56,0.56,0.33,0.5,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">delayed-release DMF BID or TID. The SF-36v1 was administered </text>
   <text y="269.082" x="49.604,53.6,56.102,58.001,62.501,66.497,69.998,73.994,76.496,78.998,83.498,87.494,89.394,93.39,97.89,102.39,104.289,108.285,112.785,116.781,119.778,124.278,126.177,130.677,135.177,137.076,143.574,147.57,151.566,156.066,159.567,161.466,163.968,168.468,172.464,175.461,179.457,183.453,186.45,188.952,192.948,195.45,197.7,199.104,205.602,208.104,210.606,215.106,219.606,224.106,228.606,233.106,235.005,239.505,243.501,246.003,249.999,251.898,258.396,262.392,265.389,269.385,271.284,275.28,279.78,282.282" svgx:width="0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.33,0.28,0.44,0.33,0.25,0.25,0.72,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">at baseline and every 48 weeks thereafter. Although data were col-</text>
   <text y="280.08" x="49.604,52.106,56.102,60.098,62.6,66.596,71.096,73.481,76.479,80.979,83.976,86.361,90.861,95.361,97.863,102.363,104.748,107.25,111.75,115.746,118.131,120.633,127.131,129.633,133.629,137.625,140.622,143.007,147.003,151.503,156.003,158.387,160.889,165.389,168.386,170.888,174.884,178.88,181.877,186.377,190.373,192.875,195.377,199.877,202.262,208.76,216.761,221.765,224.15,227.147,231.143,235.643,238.145,245.147,249.143,253.643,257.144,259.394,261.779,264.776,268.772,272.273,276.773,279.276,281.778,285.279" svgx:width="0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.72,0.28,0.44,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.25,0.72,0.89,0.56,0.25,0.33,0.44,0.5,0.28,0.78,0.44,0.5,0.39,0.25,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lected for both the twice- and thrice-daily DMF regimens, results </text>
   <text y="291.078" x="49.604,53.6,56.597,60.593,62.924,67.424,70.422,74.418,77.919,81.915,86.415,88.917,92.913,97.413,99.744,104.244,108.744,111.246,115.746,118.077,121.074,125.574,128.571,130.902,133.404,137.904,142.404,145.905,149.901,152.232,156.732,160.728,163.23,165.732,169.728,174.228,176.73,180.231,182.562,185.559,189.555,193.551,197.547,200.049,204.549,207.051,211.551,216.051,218.382,224.385,227.382,233.88,236.13,238.46,240.962,245.462,249.458,251.789,255.785,260.285,264.785,267.783,272.283,276.783,280.779,285.279" svgx:width="0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.5,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.67,0.33,0.72,0.25,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are presented only for those patients receiving BID, the approved </text>
   <text y="302.076" x="49.604,54.104,58.604,62.105,66.102,70.602,74.598,76.848,79.656,85.659,89.655,93.156,97.656,100.158,102.66,106.16,108.968,112.965,115.962,119.958,122.766,127.266,130.262,134.258,137.76,141.756,146.256,148.758,152.754,157.254,160.062,164.058,168.054,172.05,176.55,179.547,184.047,186.549,191.049,195.549,198.357,200.859,205.359,208.167,210.669,213.665,217.661,221.658,224.16,231.161,235.158,239.658,242.16,244.967,247.964,251.96,255.956,259.952,262.454,266.954,270.951,275.451,278.259,280.761,285.261" svgx:width="0.5,0.5,0.39,0.44,0.5,0.44,0.25,0.25,0.67,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dosage. Results are presented according to treatment received in </text>
   <text y="313.074" x="49.604,52.106,56.606,60.602,62.987,67.487,71.483,74.48,78.477,82.977,85.479,87.98,91.977,96.477,98.979,102.975,107.475,110.976,113.478,117.978,122.478,124.863,128.364,130.866,135.366,139.866,142.368,146.364,149.865,152.115,154.491,160.494,163.491,169.989,172.491,178.494,181.491,187.989,190.365,194.361,198.861,203.361,205.745,210.749,216.753,223.251,225.753,231.756,234.753,241.251,243.501,245.876,251.88,255.876,259.376,263.876,266.379,268.881,272.382,274.758,277.755,282.255,285.252" svgx:width="0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.44,0.5,0.5,0.25,0.56,0.67,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.67,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the parent/extension studies, BID/BID and PBO/BID. Results for </text>
   <text y="324.072" x="49.604,56.103,62.601,65.103,71.105,74.103,80.601,82.851,86.847,89.844,93.84,96.09,100.59,105.09,107.592,109.842,113.343,117.843,122.343,128.84,133.34,135.59,140.09,144.59,148.587,150.837,153.339,157.839,160.089,162.59,167.09,171.087,173.337,176.838,183.84,187.836,190.338,192.84,195.09,198.591,202.587,209.589,214.089,216.591,220.587,222.837,226.338,228.84,232.836,236.832" svgx:width="0.72,0.72,0.28,0.67,0.33,0.72,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.78,0.44,0.28,0.28,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.25,0.39,0.28,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GA/BID are not shown due to the small sample size.</text>
   <text y="335.07" x="49.604,56.103,60.098,63.599,68.604,71.105,74.103,77.604,80.601" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="335.07" x="83.049,88.548,93.048,97.044,99.492,101.993,106.493,108.995,112.992,117.492,119.993,122.991,125.493,129.992,132.989,135.491,138.488,142.484,146.48,148.982,151.43,155.93,160.43,164.93,169.43,171.932,175.928,178.43,180.932,185.432,189.932,192.38,196.376,200.876,207.878,212.378,215.375,217.877,221.378,225.374,229.874,232.322,236.822,239.072,243.572,248.072,252.572,255.02,259.52,263.516,266.018,268.521,272.517,277.017,279.519,283.02,285.27" svgx:width="0.61,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.5,0.28,0.33,0.28,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.33,0.28,0.39,0.44,0.5,0.25,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The intent-to-treat population comprised 1,500 patients, </text>
   <text y="346.068" x="49.604,52.106,56.606,60.602,63.104,67.604,72.104,74.606,79.106,83.606,86.18,90.68,95.18,99.68,102.254,105.251,111.254,114.251,120.749,123.251,129.254,132.251,138.749,141.746,144.32,148.316,152.816,157.316,159.89,164.39,168.89,173.39,175.964,178.961,183.965,189.968,196.466,198.968,204.971,207.968,214.466,217.463,219.713,221.792,228.29,230.792,233.367,237.867,240.441,244.941,248.937,252.933,255.93,259.431,262.005,265.002,272.778,276.774,280.77,285.27" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.33,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.33,0.56,0.67,0.72,0.28,0.67,0.33,0.72,0.33,0.25,0.25,0.72,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.33,0.94,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">including 501 (BID/BID) and 249 (PBO/BID). At 2 years (Week </text>
   <text y="357.066" x="49.604,54.104,58.604,61.602,63.852,65.66,70.16,73.158,75.408,77.216,82.715,89.214,95.712,102.21,108.213,113.216,118.715,120.965,123.215,125.024,132.027,136.023,140.019,144.519,146.769,148.578,152.574,157.074,161.07,165.57,170.07,174.066,176.316,178.116,180.618,185.118,187.368,189.177,193.677,198.177,202.677,206.178,208.68,212.676,216.672,219.174,221.424,223.224,227.22,231.72,238.722,243.222,247.722,252.222,256.218,260.718,263.22,265.47,267.279,270.78,274.776,278.772,281.274,285.27" svgx:width="0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.72,0.72,0.72,0.67,0.56,0.61,0.25,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.39,0.44,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">96) of ENDORSE, mean change in physical component scale </text>
   <text y="368.064" x="49.604,52.602,57.605,63.608,68.612,71.609,74.318,77.819,81.815,86.315,89.313,93.309,96.81,99.519,102.516,106.512,109.014,113.01,115.512,118.014,122.514,126.51,129.21,131.712,136.212,138.921,145.419,150.917,155.921,158.918,165.416,170.915,173.417,179.42,185.918,192.416,197.42,200.417,206.42,214.421,217.121,221.621,225.617,229.118,233.115,235.617,238.118,242.618,246.615,249.314,255.813,259.809,262.806,266.802,269.511,274.011,276.261,280.761,285.261" svgx:width="0.33,0.56,0.67,0.56,0.33,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.72,0.61,0.56,0.33,0.72,0.61,0.28,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PCS) scores relative to DEFINE/CONFIRM baseline were 1.03 </text>
   <text y="379.062" x="49.604,52.602,58.604,61.602,68.1,70.602,76.604,79.602,86.1,88.35,90.6,91.797,96.297,101.372,105.872,108.122,112.622,117.122,121.622,126.122,129.119,131.369,132.566,136.563,141.063,145.563,147.813,149.01,152.007,156.003,158.505,162.501,165.003,167.505,172.005,176.001,178.251,179.448,181.95,186.45,188.7,189.897,195.396,201.894,208.392,214.89,220.893,225.897,231.396,233.646,234.843,239.343,243.339,246.84,250.836,253.338,255.84,260.34,264.336,266.586,267.783,274.281,278.277,281.274,285.27" svgx:width="0.33,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.72,0.72,0.72,0.67,0.56,0.61,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(BID/BID, p=0.0102) and relative to ENDORSE baseline were </text>
   <text y="390.06" x="49.604,54.104,56.354,60.854,65.354,67.604,68.819,71.816,77.819,80.816,87.314,89.816,95.819,98.816,105.314,107.564,109.814,111.029,115.529,120.605,125.105,127.355,131.855,136.355,140.855,145.355,148.352,150.602,151.817,155.813,160.313,164.813,167.063,168.278,171.275,175.775,178.025,182.525,187.025,189.275,190.49,193.487,198.491,204.494,210.992,213.494,219.497,222.494,228.992,231.242,233.492,234.707,239.207,244.283,248.783,251.033,255.533,260.033,264.533,269.033,272.03,274.28,276.53,277.745,280.742,285.242" svgx:width="0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.56,0.67,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.14 (BID/BID, p=0.7292) and -0.26 (PBO/BID, p=0.9483). In </text>
   <text y="401.058" x="49.604,53.6,58.1,62.6,65.103,67.604,70.106,74.606,79.106,81.356,84.102,91.104,95.1,99.096,103.596,106.341,110.337,114.837,118.833,123.333,127.833,131.829,134.574,137.076,141.576,144.32,151.322,155.318,159.818,162.32,166.316,168.818,171.563,175.559,180.059,187.061,191.561,196.061,200.561,204.557,209.057,211.559,214.304,217.805,221.801,225.798,228.299,232.296,235.04,238.037,246.038,252.042,257.046,260.043,262.788,266.289,270.285,274.785,277.782,281.778,285.279" svgx:width="0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.33,0.89,0.67,0.56,0.33,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">addition, mean change in mental component scale (MCS) scores </text>
   <text y="412.056" x="49.604,56.103,60.098,63.096,67.091,69.341,73.787,78.287,80.537,85.037,89.537,91.787,96.233,99.23,105.233,108.23,114.729,117.23,123.233,126.23,132.729,134.979,137.229,141.674,146.174,151.251,155.751,158.001,162.501,167.001,171.501,176.001,178.997,181.247,185.693,188.69,192.686,195.188,199.184,201.686,204.188,208.688,212.684,214.934,219.38,221.882,226.382,228.632,233.078,235.58,240.08,244.076,246.326,250.772,257.27,262.769,267.773,270.77,277.268,282.767" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.61,0.56,0.33,0.72,0.61,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were 0.49 (BID/BID, p=0.3885) relative to the DEFINE/</text>
   <text y="423.054" x="49.604,55.607,62.105,68.604,73.607,76.604,82.607,90.608,92.858,93.947,98.447,102.443,105.944,109.94,112.442,114.944,119.444,123.44,125.69,127.94,129.029,133.025,137.525,142.025,144.275,145.365,148.361,152.861,155.111,159.611,164.111,166.361,167.451,170.447,176.451,179.447,185.945,188.447,194.451,197.447,203.945,206.195,208.445,209.535,214.035,219.111,223.611,225.861,230.361,234.861,239.361,243.861,246.857,249.107,250.197,254.193,258.693,263.193,265.443,266.531,269.529,274.029,276.279,280.779,285.279" svgx:width="0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CONFIRM baseline, and -0.16 (BID/BID, p=0.6278) and -1.81 </text>
   <text y="434.052" x="49.604,52.602,57.605,63.608,70.106,72.608,78.611,81.608,88.106,90.356,92.606,96.917,101.417,106.493,110.993,113.243,117.743,122.243,126.743,131.243,134.24,136.49,140.801,143.798,147.794,150.296,154.292,156.794,159.296,163.796,167.792,170.042,174.354,176.855,181.355,183.605,187.917,190.419,194.919,198.915,201.165,205.476,210.975,217.473,223.971,230.469,236.472,241.476,246.975,249.225,253.536,258.036,262.032,265.533,269.529,272.031,274.533,279.033,283.029,285.279" svgx:width="0.33,0.56,0.67,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.72,0.72,0.67,0.56,0.61,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PBO/BID, p=0.0070) relative to the ENDORSE baseline. </text>
   <text y="445.05" x="49.604,55.607,60.107,64.104,68.604,73.104,77.1,80.601,83.058,86.055,90.051,92.553,96.549,99.051,101.553,106.053,110.049,112.506,115.008,119.508,121.965,124.467,128.967,132.963,135.42,141.918,147.417,152.421,155.417,161.915,167.414,169.916,175.919,182.417,188.915,193.919,196.916,202.919,210.921,213.378,217.878,221.874,225.375,229.371,231.873,234.375,238.875,242.871,245.328,249.324,252.321,256.316,258.773,262.77,267.27,271.77,275.271,277.773,282.273" svgx:width="0.67,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.61,0.56,0.33,0.72,0.61,0.28,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Changes relative to the DEFINE/CONFIRM baseline are consid-</text>
   <text y="456.048" x="49.604,53.6,56.597,60.593,65.093,67.361,74.363,78.863,82.364,84.866,87.134,90.131,94.127,96.629,100.625,105.125,109.121,113.621,116.123,118.382,121.379,125.879,128.876,131.145,137.148,140.145,146.643,149.145,155.148,158.145,164.643,166.893,169.161,173.157,176.658,178.926,181.428,185.928,189.924,193.425,197.421,199.68,204.18,208.176,210.678,215.178,219.174,222.675,224.943,228.939,233.439,237.939,242.439,246.435,250.935,253.203,255.705,260.205,264.201,266.46,270.96,275.46,279.456,282.263" svgx:width="0.44,0.33,0.44,0.5,0.25,0.78,0.5,0.39,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.67,0.33,0.72,0.28,0.67,0.33,0.72,0.25,0.25,0.44,0.39,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.44,0.5,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ered most relevant for BID/BID, as these values convey the over-</text>
   <text y="467.046" x="49.604,53.6,56.102,58.604,60.854,65.3,69.296,72.131,75.128,79.124,83.12,85.622,87.872,92.318,96.818,99.815,102.065,106.511,111.011,115.007,117.509,121.506,126.006,130.001,134.501,137.498,140.495,144.491,146.993,150.989,154.985,158.486,162.482,164.732,169.178,175.676,183.678,188.682,190.932,195.378,199.878,204.378,207.879,210.381,214.881,219.381,221.631,226.077,229.578,232.08,236.58,240.576,244.572,246.822,251.268,253.77,256.767,260.763,264.759,267.261,274.263,278.259,282.759,285.261" svgx:width="0.44,0.28,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.72,0.89,0.56,0.25,0.55,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.44,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">all effect of delayed-release DMF dosing since treatment </text>
   <text y="478.044" x="49.604,52.106,56.606,59.108,61.61,64.112,68.108,70.61,73.112,77.612,82.112" svgx:width="0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">initiation.</text>
   <text y="489.042" x="49.604,56.102,60.602,65.606,69.602,72.104,77.108,80.609,83.111,87.611,92.615,96.116,99.113" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="489.042" x="102.182,107.186,114.188,118.184,120.686,123.188,125.438,127.688,128.507,132.008,134.51,138.507,141.008,143.51,147.012,149.514,152.016,156.012,160.008,162.51,165.012,169.512,171.762,172.581,176.082,178.584,183.084,187.584,190.086,193.083,195.585,199.581,203.577,208.077,210.579,212.829,213.648,217.644,222.144,226.14,230.64,235.14,239.136,242.637,244.887,245.706,248.703,251.7,256.2,263.202,265.452,266.271,270.771,274.767,278.268,282.264" svgx:width="0.56,0.78,0.44,0.28,0.28,0.25,0.25,0.55,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Small, statistically significant changes from base-</text>
   <text y="500.04" x="49.604,52.106,54.608,59.108,63.104,65.354,66.875,69.377,73.877,76.127,77.648,81.149,85.649,92.651,96.647,98.897,100.418,104.918,107.915,110.165,111.686,114.188,118.688,122.684,124.934,126.455,131.459,137.462,142.466,144.968,152.969,158.973,163.977,166.227,167.747,171.249,175.245,179.745,182.742,186.738,190.239,192.489,194.01,200.508,204.504,207.501,211.497,213.747,215.268,219.768,224.268,227.769,231.765,234.762,239.262,243.258,247.758,250.008,252.258,253.779,257.775,260.277,262.779,267.279,271.779,276.279,280.779,285.279" svgx:width="0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.5,0.78,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.67,0.56,0.28,0.89,0.67,0.56,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.25,0.55,0.44,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line in some of the PCS/MCS scores were observed, although </text>
   <text y="511.038" x="49.604,52.106,56.606,60.602,64.103,68.099,70.349,71.537,78.539,82.535,87.035,89.285,90.474,93.471,97.467,100.464,102.966,106.962,110.958,113.46,115.71,116.898,119.895,123.891,128.391,132.891,137.391,144.393,146.643,147.831,152.331,156.327,159.324,161.826,165.822,168.324,170.826,175.326,179.826,183.327,185.577,187.827,189.015,195.513,200.013,204.513,208.509,211.011,215.007,219.507,221.757,222.945,227.445,231.441,233.943,237.939,240.189,241.377,247.875,250.377,252.879,255.381,257.631,258.819,263.319,267.315,269.565,270.753,275.253,278.25,282.246" svgx:width="0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.33,0.44,0.33,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.72,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.28,0.25,0.55,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">these may reflect random variations. Updated data will be pre-</text>
   <text y="522.036" x="49.604,53.105,57.101,61.601,64.103,68.099,72.599,74.849,77.594,80.096,84.596,88.592,91.094,95.594,100.094,102.596,107.096,111.596,114.341,118.338,120.84,123.341,127.841,130.344,134.34,138.336,140.838,143.34,147.84,150.585,153.581,157.577,160.079,164.076,168.576,172.572,177.072,179.574,182.318,186.314,190.814,194.811,199.311,203.811,207.807,211.308,214.053,217.049,221.99,226.49,229.235,233.735,238.235,240.737,245.237,247.739,251.24,254.237,256.982,259.484,263.984,266.729,271.733,277.736,282.74" svgx:width="0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.33,0.55,0.5,0.25,0.5,0.5,0.28,0.5,0.28,0.39,0.33,0.25,0.28,0.5,0.25,0.56,0.67,0.56,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sented, including clinically relevant changes (≥5 points) in PCS/</text>
   <text y="533.034" x="49.604,57.605,63.608,68.612,70.862,74.363,78.359,82.859,85.856,89.853,93.354" svgx:width="0.89,0.67,0.56,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MCS scores.</text>
   <text y="560.034" x="49.604,55.103,59.603,64.104" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P791</text>
   <text y="571.032" x="49.604,58.1,63.104,65.354,71.852,74.354,77.351,82.355,84.605,89.105,93.101,97.097,100.598,105.602,109.103,111.353,117.851,120.353,123.35,128.354,132.854,137.858,140.855,143.105,147.101,151.097,153.599,158.099,163.103,166.604,170.6,172.85,175.847,178.097,181.094,186.098,190.094,192.344,197.348,201.848,204.845,207.347,211.343,216.347,219.344,221.594,226.598,230.594,234.59,238.091,243.095,247.091,251.087,254.084,256.586,261.086,265.082" svgx:width="0.94,0.56,0.25,0.72,0.28,0.33,0.56,0.25,0.5,0.44,0.44,0.39,0.56,0.39,0.25,0.72,0.28,0.33,0.56,0.5,0.56,0.33,0.25,0.44,0.44,0.28,0.5,0.56,0.39,0.44,0.25,0.33,0.25,0.33,0.56,0.44,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.25,0.56,0.44,0.44,0.39,0.56,0.44,0.44,0.33,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">MS with versus without relapse - the patient perspective </text>
   <text y="582.03" x="49.604,52.106,57.11,59.36,62.357,67.361,71.357,73.607,79.106,85.109,91.607,98.105,104.108,106.358,109.859,112.856,117.86,122.864" svgx:width="0.28,0.56,0.25,0.33,0.56,0.44,0.25,0.61,0.67,0.72,0.72,0.67,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">in the PEARL study</text>
   <text y="593.028" x="49.604,54.608,61.106,63.356,69.854,74.354,77.352,84.354,87.351,91.347,93.849,98.349" svgx:width="0.56,0.72,0.25,0.72,0.5,0.33,0.78,0.33,0.44,0.28,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">SV Vormfelde</text>
   <text y="590.592" x="102.346" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="593.112" x="105.271,107.521,109.771,114.775,117.025,122.029,126.025,128.527,133.027,137.023,140.02" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.28,0.5,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Seibert</text>
   <text y="590.592" x="142.521" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="593.112" x="145.446,147.696,149.946,155.445,157.695,162.195,166.191,170.691,172.941,178.44,182.94,187.44,191.94,195.936" svgx:width="0.25,0.25,0.61,0.25,0.5,0.44,0.5,0.25,0.61,0.5,0.5,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T van Lokven</text>
   <text y="590.592" x="200.436" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="593.112" x="203.361,205.611,207.861,212.865,215.115,221.613,224.61,227.112,229.614,233.61" svgx:width="0.25,0.25,0.56,0.25,0.72,0.33,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Ortler</text>
   <text y="590.592" x="236.606" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="593.112" x="239.531,241.781,244.031,249.035" svgx:width="0.25,0.25,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S </text>
   <text y="604.11" x="49.604,57.605,62.105,65.606,69.602" svgx:width="0.89,0.5,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Moser</text>
   <text y="601.592" x="72.601" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="604.112" x="75.526,77.776,80.026,86.524,88.774,93.778,98.278,102.274,106.774" svgx:width="0.25,0.25,0.72,0.25,0.56,0.5,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Fuchs</text>
   <text y="601.592" x="110.275" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="604.112" x="113.2,115.45,117.7,123.199,125.449,130.948,133.45,137.446,144.448,147.949,151.45,155.446" svgx:width="0.25,0.25,0.61,0.25,0.61,0.28,0.44,0.78,0.39,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Ziemssen</text>
   <text y="601.592" x="159.945" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="612.59" x="49.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="615.112" x="52.531,58.534,63.034,67.03,71.53,75.031,77.533,80.035,83.536,85.786,88.036,94.039,98.539,102.04,106.036,112.534,117.034,121.03,124.531,129.031,131.281,133.531,140.029,144.025,147.526,154.024,158.524,163.024,167.02,169.27" svgx:width="0.67,0.5,0.44,0.5,0.39,0.28,0.28,0.39,0.25,0.25,0.67,0.5,0.39,0.44,0.72,0.5,0.44,0.39,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Novartis, Nuremberg, Germany, </text>
   <text y="612.592" x="171.519" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="615.112" x="174.444,180.942,185.442,187.944,191.94,195.936,199.437,202.938,205.44,207.942,212.442,214.944,218.445,222.441,224.943,227.445,231.945,234.447,238.443,242.943,249.441,251.691,257.694,262.194,265.695,268.197" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.28,0.39,0.44,0.28,0.28,0.5,0.28,0.44,0.5,0.72,0.25,0.67,0.5,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Universitätsklinikum Karl </text>
   <text y="626.11" x="49.605,56.103,60.603,64.104,66.606,71.106,75.102,77.352,83.355,87.855,91.356,95.856,99.357,101.607,103.857,110.355,113.856,117.852,121.353,125.853,129.849,134.349,136.599,138.849,145.347,149.343,152.844,159.342,163.842,168.342" svgx:width="0.72,0.5,0.39,0.28,0.5,0.44,0.25,0.67,0.5,0.39,0.5,0.39,0.25,0.25,0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Gustav Carus, Dresden, Germany</text>
   <text y="653.11" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.954,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="653.11" x="104.487,109.986,114.486,118.482,120.732,123.018,128.022,133.521,140.019,146.022,151.188,153.438,155.724,159.225,161.727,166.227,170.727,175.227,177.477,179.763" svgx:width="0.61,0.5,0.44,0.25,0.55,0.56,0.61,0.72,0.67,0.61,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The PEARL study (</text>
   <text y="653.11" x="182.76" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P</text>
   <text y="653.11" x="188.259,191.256,195.756,199.257" svgx:width="0.33,0.5,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rosp</text>
   <text y="653.11" x="203.757" svgx:width="0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">E</text>
   <text y="653.11" x="209.76,213.756,216.258,218.76,223.26,227.256,229.506,231.792,236.292" svgx:width="0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ctive ph</text>
   <text y="653.11" x="240.792" svgx:width="0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">A</text>
   <text y="653.11" x="247.29,250.287,257.289,261.285,265.281,269.781,273.777,277.773,282.273" svgx:width="0.33,0.78,0.44,0.44,0.5,0.44,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rmacoeco-</text>
   <text y="664.108" x="49.605,54.105,58.605,65.607,68.109,72.105,74.346,78.342,82.842,87.342" svgx:width="0.5,0.5,0.78,0.28,0.44,0.25,0.44,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nomic coho</text>
   <text y="664.108" x="91.842" svgx:width="0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">R</text>
   <text y="664.108" x="98.34,100.842,103.083,107.079,111.579" svgx:width="0.28,0.25,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">t eva</text>
   <text y="664.108" x="115.575" svgx:width="0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">L</text>
   <text y="664.108" x="121.578,126.078,130.074,132.576,135.078,139.578,144.078,147.075,149.316,152.313,156.813,160.809,165.309,168.81,172.311,176.307,179.808,182.049,186.549,191.049,193.29,196.287,200.283,204.279,206.781,209.022,215.52,220.02,223.017,225.519,230.019,232.26,236.256,239.757,244.257,248.253,252.249,254.751,258.252,260.493,264.993,267.99,270.231,274.731,277.728,282.228" svgx:width="0.5,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.33,0.5,0.44,0.5,0.39,0.39,0.44,0.39,0.25,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.25,0.72,0.5,0.33,0.28,0.5,0.25,0.44,0.39,0.5,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">uation) focusses on real world aspects of pro-</text>
   <text y="675.106" x="49.605,54.105,56.607,61.107,63.609,68.109,72.609,74.859,79.359,83.355,87.351,89.853,92.355,96.855,99.105,103.101,107.097,110.094,114.09,116.34,119.337,123.837,126.834,129.084,137.085,142.089,144.339,148.839,152.835,155.337,157.839,161.835,166.335,168.837,172.338,174.588,177.09,181.59,183.84,190.338,194.334,197.331,204.333,208.329,212.829,216.744" svgx:width="0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.44,0.33,0.44,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.72,0.44,0.33,0.78,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">viding health care for MS patients in Germany.</text>
   <text y="686.104" x="49.605,56.742,61.881,65.013,69.144,73.275,76.407,79.044,83.679,87.81,91.446,94.578" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="686.104" x="97.485,104.118,108.249,111.381,115.512,118.419,125.052,129.183,132.09,135.222,139.857,143.988,148.623,152.259,155.166,159.801,164.436,167.343,169.98,174.615,178.746,181.653,186.288,190.419,193.056,195.693,199.824,204.459,207.096,210.003,214.638,218.769,221.901,225.537,230.172,234.303,238.434,241.071,243.708,248.343,252.474,255.381,258.018,262.653,265.56,268.197,271.329,275.46,279.591,282.228" svgx:width="0.72,0.44,0.33,0.44,0.25,0.72,0.44,0.25,0.33,0.5,0.44,0.5,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Here we focus on the patient perspective to treat-</text>
   <text y="697.102" x="49.605,56.742,60.873,65.508,68.145,70.395,71.079,74.715,78.846,81.483,84.12,87.756,90.888,95.019,99.15,101.787,104.424,109.059,113.694,116.079,118.329,119.013,123.648,127.779,131.91,134.547,137.184,141.819,144.069,144.753,148.389,151.026,155.157,157.794,161.925,164.175,164.859,168.99,173.625,178.26,180.51,181.194,185.829,190.464,194.595,197.232,199.869,202.506,207.141,209.391,210.075,214.71,217.842,220.092,220.776,223.413,226.05,229.182,233.313,235.698,238.47,246.381,250.512,252.762,253.446,257.577,262.212,269.349,273.984,278.115,281.247,285.243" svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.33,0.44,0.25,0.25,0.94,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment satisfaction, health state and quality of life. We compare </text>
   <text y="708.1" x="49.605,54.24,58.371,61.008,63.645,67.776,72.411,75.048,78.684,81.465,88.098,90.735,93.372,98.007,100.788,104.919,107.7,110.832,114.963,117.6,121.731,126.366,130.002,134.133,136.914,139.551,144.186,146.967,149.604,154.239,158.37,161.151,164.283,166.92,170.052,173.688,176.325,179.106,182.742,185.379,190.014,194.649,199.284,202.065,206.7,210.831,214.962,218.094,220.875,224.007,230.64,236.778,242.412,245.544,252.177,257.811,260.592,265.227,268.359,272.994,277.629,282.264,285.261" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.33,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with a relapse in the first study year (ACTIVE group) </text>
   <text y="719.098" x="49.605,52.242,56.877,59.244,63.879,68.01,70.647,73.284,77.415,82.05,84.687,88.323,90.69,97.323,99.96,102.597,107.232,111.867,116.502,119.139,121.506,125.637,128.004,131.136,135.267,137.904,142.035,146.67,150.306,154.437,156.804,159.441,164.076,166.443,169.08,173.715,177.846,180.213,183.345,185.982,189.114,192.75,195.387,197.754,201.39,204.027,208.662,213.297,217.932,220.299,224.934,229.065,233.196,236.328,238.695,241.827,244.959,251.592,258.225,264.363,269.997,273.129,279.762,285.261" svgx:width="0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.33,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to patients without a relapse in the first study year (INACTIVE </text>
   <text y="730.096" x="49.605,54.24,57.372,62.007,66.642,71.277,74.409" svgx:width="0.5,0.33,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">group).</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 549.300 L344.510 549.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,305.756,309.752,312.749,317.753,322.253,327.257,330.758,333.755" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="77.103" x="337.643,342.647,348.146,354.644,360.647,365.813,368.063,369.701,372.203,375.704,377.954,379.592,383.588,385.838,387.476,391.976,396.476,399.473,406.475,410.975,415.475,417.977,422.477,425.978,428.228,430.478,432.116,436.616,441.116,445.616,448.613,451.115,455.615,458.117,462.113,465.11,469.61,473.606,478.106,480.608,483.11,487.61,492.11,496.106,498.608,500.858,502.496,505.997,508.499,512.999,517.499,521.999,524.249,525.887,528.389,532.889" svgx:width="0.56,0.61,0.72,0.67,0.61,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.33,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PEARL is a 24-months, non-interventional study in </text>
   <text y="88.101" x="297.26,301.76,306.26,310.76,315.26,317.177,321.677,325.673,328.175,330.677,334.673,339.173,341.675,345.176,347.093,353.591,356.093,358.595,363.095,365.012,368.009,372.005,374.507,378.503,383.003,386.504,389.006,393.506,398.006,399.923,402.92,406.916,413.918,416.42,418.922,421.424,423.926,428.426,432.926,434.843,441.845,446.345,448.847,451.349,453.851,458.351,460.853,464.849,466.766,470.267,474.263,476.765,480.761,483.758,488.258,491.759,494.261,497.762,499.679,502.676,508.679,514.682,522.683,527.687,530.684,532.934" svgx:width="0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1705 patients with relapsing remitting multiple sclerosis (RRMS). </text>
   <text y="99.099" x="297.26,303.758,306.755,308.807,313.307,317.807,322.307,326.807,328.859,333.359,337.355,339.857,342.359,346.355,350.855,353.357,356.858,359.108,361.16,365.66,370.16,374.66,379.16,381.212,385.712,389.708,392.21,394.712,398.708,403.208,405.71,409.211,411.263,415.763,419.264,423.26,427.76,429.812,432.314,436.814,439.316,443.312,447.308,449.81,453.806,458.306,460.808,464.804,466.856,469.358,473.858,476.36,480.356,483.353,486.35,490.346,493.343,497.843,502.343,504.395,508.391,512.891,517.391,519.443,523.943,528.443,532.943" svgx:width="0.72,0.33,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Of 1705 patients, 1214 patients used injectable interferon and 491 </text>
   <text y="110.097" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,325.259,327.509,330.011,334.511,337.013,341.009,345.005,347.507,351.503,356.003,358.253,362.753,365.255,369.251,371.753,374.255,377.252,381.248,388.25,392.246,395.243,397.493,401.489,405.485,409.481,411.983,415.979,418.481,422.477" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients injected glatiramer acetate.</text>
   <text y="121.095" x="309.257,312.164,316.574,318.824,321.281,323.693,328.103,332.009,334.259,336.716,339.623,342.035,344.942,348.353,350.765,353.015,355.472,358.883,361.295,365.705,370.115,374.525,376.775,379.232,383.642,387.548,391.454,394.001,396.161,398.411,400.868,405.278,409.355,413.765,416.015,418.472,422.882,426.788,429.2,431.612,435.518,439.928,442.34,445.751,448.001,450.458,453.365,457.271,459.683,463.589,467.999,471.41,475.316,479.726,481.976,484.433,488.339,490.751,493.001,495.458,497.87,501.776,505.682,509.093,511.505,513.755,516.212,520.622,525.032,528.938,532.934" svgx:width="0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.39,0.28,0.25,0.55,0.5,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In the first study year, 411 patients relapsed at least once </text>
   <text y="132.093" x="297.26" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(</text>
   <text y="132.093" x="300.167,306.575,312.983,318.896,322.307,328.715,334.628,336.338,340.748,344.492,348.902,353.816,358.73,360.89,362.6,367.01,373.418" svgx:width="0.72,0.72,0.67,0.39,0.72,0.67,0.25,0.5,0.44,0.5,0.56,0.56,0.25,0.25,0.5,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">ACTIVE group, “A”</text>
   <text y="132.093" x="377.828,380.735,383.147,384.857,389.267,393.677,398.087,402.497,404.207,408.617,412.523,414.935,417.347,421.253,425.663,428.075,431.486,433.196,437.606,440.018,444.428,446.138,450.548,454.958,457.37,459.08,461.987,465.893,468.305,472.211,476.621,480.032,483.938,485.648" svgx:width="0.33,0.28,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">); 1294 patients did not relapse (</text>
   <text y="132.093" x="488.555,491.966,498.374,504.782,511.19,517.103,520.514,526.922,532.925" svgx:width="0.39,0.72,0.72,0.72,0.67,0.39,0.72,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">INACTIVE </text>
   <text y="143.091" x="297.26,301.67,305.414,309.824,314.738,319.652,321.812,324.062,324.881,329.291,332.702" svgx:width="0.5,0.44,0.5,0.56,0.56,0.25,0.25,0.55,0.5,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">group, “I”</text>
   <text y="143.091" x="337.112,340.019,342.179,344.429,345.248,353.159,358.073,360.323,361.142,363.554,367.46,370.871,373.283,377.189,381.599,383.849,384.668,389.078,391.238,395.648,400.499,404.909,407.069,411.479,413.729,414.548,418.454,422.864,427.274,429.524,430.343,434.753,436.913,441.323,446.174,450.584,452.744,457.154,459.404,460.223,464.633,468.539,472.445,475.352,478.763,481.013,481.832,484.739,491.651,495.557,499.463,503.873,508.724,513.638,520.046,522.953,525.203,526.022,528.434,532.934" svgx:width="0.33,0.25,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.33,0.78,0.44,0.44,0.5,0.55,0.56,0.72,0.33,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">). MS lasted 5.1±4.4 and 5.2±4.3 years (mean±SD) in </text>
   <text y="154.089" x="297.26,303.668,309.581,314.99,317.897,324.305,329.714,332.432,336.338,340.748,345.158,347.876,350.783,357.191,363.599,369.512,374.921,377.828,384.236,389.645,392.363,396.773,400.679,403.091,405.503,409.409,413.819,416.231,419.642,421.802,424.52,427.427,431.333,434.744,439.154,443.06,446.966,449.378,451.79,456.2,460.106,462.518,466.343,468.503,471.059,476.468,480.878,484.784,487.502,494.414,498.32,502.226,506.636,509.354,513.26,517.67,522.08,526.49,530.396,532.898" svgx:width="0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.44,0.5,0.5,0.25,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ACTIVE and INACTIVE patients, respectively. The mean annual </text>
   <text y="165.087" x="297.26,300.167,304.073,306.485,310.391,314.801,318.212,322.118,323.981,326.888,330.794,333.206,337.112,338.975,345.383,349.289,352.7,354.563,358.973,361.133,365.543,370.394,374.804,376.964,381.374,383.237,387.143,391.553,395.963,397.826,402.236,404.396,408.806,413.657,418.067,420.227,424.637,426.5,429.407,433.313,435.725,439.631,444.041,447.452,451.358,454.769,457.181,461.591,465.497,469.403,472.31,474.173,477.08,483.992,487.898,491.804,496.214,501.065,505.979,512.387,515.294,517.157,521.567,525.977,529.883,532.88" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.28,0.5,0.44,0.44,0.33,0.25,0.33,0.78,0.44,0.44,0.5,0.55,0.56,0.72,0.33,0.25,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapse rate was 1.4±1.0 and 0.1±0.2 relapses/year (mean±SD) over </text>
   <text y="176.085" x="297.26,299.672,304.082,307.988,309.923,312.335,318.743,323.153,325.088,329.498,333.404,337.31,340.217,342.152,346.562,350.468,353.375,355.787,360.197,364.607,366.767,368.207,374.615,380.528,385.937,388.844,395.252,400.661,402.596,407.006,410.912,413.324,415.736,419.642,424.052,426.464,429.875,431.81,435.221,441.629,444.041,446.453,450.359,454.769,458.675,463.085,465.02,469.43,472.337,476.747,481.157,483.092,486.998,491.408,495.818,497.753,502.163,504.575,507.986,511.892,516.302,520.712,523.124,525.536,529.946" svgx:width="0.28,0.5,0.44,0.25,0.28,0.72,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.25,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.72,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the two year period. ACTIVE patients switched drug and discontin-</text>
   <text y="187.083" x="297.26,301.67,305.576,309.986,312.146,314.558,318.968,322.874,325.781,329.687,334.097,338.507,340.667,347.579,351.989,354.896,358.802,360.962,363.869,366.776,370.682,375.092,379.502,383.408,387.818,390.23,392.642,397.052,399.212,402.119,408.527,410.939,413.099,417.509,421.919,429.326,431.486,435.392,439.802,444.212,446.372,450.782,455.192,462.599,464.759,466.919,469.826,472.238,474.398,478.808,483.218,490.625,492.785,496.691,501.101,505.511,507.671,512.081,516.491,523.898,526.805" svgx:width="0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.78,0.5,0.33,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.72,0.28,0.25,0.5,0.5,0.83,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.33,0.28,0.25,0.5,0.5,0.83,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ued therapy more frequently (A: 30% and 35%, I: 12% and 18%).</text>
   <text y="198.081" x="297.26,303.758,307.754,311.255,316.259,318.761,321.758,325.259,328.256" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="198.081" x="333.872,339.875,344.375,351.377,355.877,359.873,362.87,366.866,371.366,373.868,377.864,380.114,383.48,386.477,389.474,393.47,397.466,399.968,402.47,406.97,411.47,414.971,417.221,420.587,425.087,428.084,430.334,433.205,439.703,445.706,451.205,454.202,460.7,466.199,468.449,471.815,475.811,480.311,484.811,487.061,490.427,493.424,499.922,506.42,512.423,517.922,520.919,527.417,532.916" svgx:width="0.67,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Comparable fractions of ACTIVE and INACTIVE </text>
   <text y="209.079" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,325.259,328.031,334.529,338.525,341.522,345.518,348.29,352.286,356.786,360.782,363.779,368.279,371.051,374.552,378.548,381.05,383.552,387.053,390.05,392.552,396.548,401.048,405.044,407.816,412.316,415.313,418.085,422.081,426.077,430.577,433.079,436.076,440.072,447.074,451.07,453.572,458.072,460.844,464.345,468.341,470.843,473.345,476.846,479.843,482.345,486.341,490.841,494.837,497.609,504.107,506.609,509.111,513.611,516.383,518.885,523.385,527.381,529.883,532.88" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33,0.5,0.25,0.39,0.44,0.28,0.28,0.39,0.33,0.28,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.78,0.44,0.28,0.5,0.25,0.39,0.44,0.28,0.28,0.39,0.33,0.28,0.44,0.5,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients were “very satisfied” or “extremely satisfied” with their </text>
   <text y="220.077" x="297.26,304.262,308.258,312.758,315.26,319.256,323.252,325.754,328.256,332.756,337.256,339.587,343.583,346.085,348.416,352.916,356.912,360.413,364.409,366.911,369.413,373.913,377.909,380.24,384.236,387.737,390.068,397.07,401.066,405.062,408.563,413.063,416.06,420.056,424.556,426.887,431.387,435.887,438.218,440.72,445.22,449.216,451.385,456.569,459.566,463.562,467.558,470.06,477.062,481.058,485.558,488.06,490.391,495.395,499.391,501.893,504.395,507.896,510.893,514.889,518.885,521.387,523.889,528.389,532.889" svgx:width="0.78,0.44,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.39,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.56,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">medication at baseline as measured by the Treatment Satisfaction </text>
   <text y="231.075" x="297.26,303.758,308.258,312.254,315.755,318.257,320.759,325.259,329.759,334.259,338.255,340.757,343.754,347.75,350.0,352.313,355.31,359.81,362.807,365.057,367.37,375.371,379.367,383.867,386.369,390.365,394.361,396.863,399.365,403.865,408.365,410.615,412.928,415.925,421.424,426.428,432.926,440.927,443.924,448.424,451.421,453.671,455.921,458.234,464.732,469.232,473.228,476.225,478.475,480.788,483.29,487.79,491.786,494.036,496.349,500.849,505.349,507.599,509.912,516.914,521.414,525.914,528.416,532.916" svgx:width="0.72,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.89,0.44,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.61,0.56,0.72,0.89,0.33,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Questionnaire for Medication (TSQM-9). Over the 24 month </text>
   <text y="242.073" x="297.26,300.761,303.263,307.763,312.263,316.763,319.013,322.334,326.834,330.83,333.827,336.329,340.829,345.329,347.579,349.829,353.15,356.651,360.647,363.149,365.651,369.152,372.149,376.145,380.141,382.643,385.145,389.645,394.145,396.395,399.716,404.216,408.212,412.208,414.71,417.212,421.712,425.708,430.208,432.458,435.779,439.775,444.275,448.775,451.277,453.779,458.279,462.779,467.279,471.779,475.28,477.782,482.282,484.532,487.853,490.355,494.855,497.105,499.931,506.429,512.432,517.931,520.928,527.426,532.925" svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">study period, satisfaction declined continuously in ACTIVE </text>
   <text y="253.071" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,325.259,327.509,329.759,332.927,339.425,343.925,346.427,348.929,352.925,355.175,358.343,361.34,365.336,367.838,372.338,376.334,379.331,381.581,384.749,387.251,391.751,395.747,398.744,402.74,406.736,410.237,412.739,417.239,421.739,423.989,427.157,429.659,434.159,436.409,439.577,442.574,449.072,455.57,461.573,467.072,470.069,476.567,482.066,484.316,487.484,491.984,495.98,498.482,500.984,504.98,509.48,511.982,515.483,517.733,520.901,523.898,530.396,532.898" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.33,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.72,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients, while rather increasing in INACTIVE patients (A: </text>
   <text y="264.069" x="297.26,301.76,306.26,313.757,322.757,327.257,331.757,339.254,341.504,343.754,346.751,349.253,351.503,356.003,360.503,368.0,377.0,381.5,386.0,393.497,396.494" svgx:width="0.5,0.5,0.83,1.0,0.5,0.5,0.83,0.25,0.25,0.33,0.28,0.25,0.5,0.5,0.83,1.0,0.5,0.5,0.83,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">54%→36%, I: 52%→55%).</text>
   <text y="275.067" x="309.257,314.351,318.941,323.531,326.123,330.209,334.295,336.887,339.479,344.069,348.155,350.405,354.131,358.721,362.807,367.397,371.483,374.57,378.656,381.248,383.498,387.224,391.814,395.9,399.986,402.578,405.17,409.76,412.01,415.736,419.327,421.919,426.005,428.597,432.683,434.933,438.659,445.247,449.333,452.924,455.174,458.9,465.488,470.078,473.165,476.756,480.842,483.092,486.818,489.41,494.0,496.25,499.481,506.069,512.162,517.751,520.838,527.426,532.925" svgx:width="0.56,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.72,0.5,0.33,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Subjective general health state was worse in ACTIVE </text>
   <text y="286.065" x="297.26,301.85,305.936,308.528,311.12,315.206,319.796,322.388,325.979,328.229,330.875,334.961,338.552,340.802,343.448,350.54,354.626,358.712,362.303,366.893,369.98,374.066,378.656,380.906,383.552,388.142,392.732,394.982,397.628,400.22,404.81,408.896,411.146,413.792,419.381,425.969,429.056,433.646,440.234,442.484,445.13,448.721,452.807,456.893,459.485,463.571,465.911,468.161,470.807,475.397,479.483,482.075,486.161,489.248,491.84,496.43,499.517,503.603,506.195,510.281,514.871,517.121,519.767,523.853,528.443,532.943" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.33,0.5,0.72,0.25,0.55,0.39,0.44,0.44,0.28,0.44,0.25,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.28,0.5,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients as measured by the EQ-5D scale, deteriorated and </text>
   <text y="297.063" x="297.26,300.347,304.433,311.525,315.611,318.203,322.793,326.879,331.469,333.719,334.43,337.022,341.612,348.2,350.45,351.161,355.751,360.341,364.427,367.514,369.764,370.475,375.065,379.655,381.905,382.616,389.708,394.298,398.888,401.48,406.07,409.661,412.001,414.251,414.962,421.55,426.14,428.732,431.324,435.41,437.66,438.371,440.963,448.055,452.645,455.732,460.322,464.912,467.504,472.094,476.684,478.934,479.645,482.237,486.827,489.077,489.788,492.875,499.463,506.051,512.144,517.733,520.82,527.408,532.907" svgx:width="0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.72,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remained low over 24 months, while improving in INACTIVE </text>
   <text y="308.061" x="297.26,301.85,305.936,308.528,311.12,315.206,319.796,322.388,325.979,328.706,331.793,338.381,340.973,343.7,348.29,352.88,355.22,359.81,368.9,373.49,378.08,380.42,385.01,387.35,390.077,393.164,395.756,398.483,403.073,407.663,410.003,414.593,423.683,428.273,432.863,435.203,439.793,442.88,445.22,447.452,454.04,460.133,465.722,468.809,475.397,480.986,483.713,488.303,492.389,494.981,497.573,501.659,506.249,508.841,512.432,515.159,521.747,525.833,528.92,532.916" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.28,0.25,0.5,0.5,0.25,0.5,1.0,0.5,0.5,0.25,0.5,0.25,0.25,0.33,0.28,0.25,0.5,0.5,0.25,0.5,1.0,0.5,0.5,0.25,0.5,0.33,0.25,0.25,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients (A: 69.9→68.0, I: 72.0→73.2). ACTIVE patients were </text>
   <text y="319.059" x="297.26,303.848,308.438,311.525,315.116,319.202,321.659,326.249,329.174,332.261,334.718,338.804,341.891,344.483,348.569,351.656,354.113,358.703,363.293,365.75,372.842,377.432,382.022,384.614,389.204,392.795,395.252,397.844,402.434,404.891,408.977,411.569,414.161,416.618,419.705,422.297,426.887,430.973,433.43,439.019,445.607,448.694,453.284,459.872,462.329,466.919,469.511,476.603,480.689,485.279,488.87,491.462,496.052,500.642,504.233,506.573,509.03,514.619,516.959,521.549,523.889,526.346,530.432,532.934" svgx:width="0.72,0.5,0.33,0.39,0.44,0.25,0.5,0.33,0.33,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.33,0.28,0.5,0.44,0.25,0.61,0.72,0.33,0.5,0.72,0.25,0.5,0.28,0.78,0.44,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.61,0.25,0.5,0.25,0.25,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">worse off after 24 months in all five EQ-5D dimensions. E.g. at </text>
   <text y="330.057" x="297.26,301.85,305.936,309.527,313.613,316.205,318.797,323.387,327.473,329.813,332.603,337.193,341.783,349.37,351.665,358.253,364.346,369.935,373.022,379.61,385.199,387.989,392.075,396.665,401.255,404.045,408.635,413.225,420.812,423.602,426.689,433.277,439.865,445.958,451.547,454.634,461.222,466.811,469.601,474.191,478.277,480.869,483.461,487.547,492.137,494.729,498.32,501.11,505.7,509.786,514.376,517.166,521.756,525.842,528.434,532.934" svgx:width="0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.5,0.83,0.25,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">baseline, 52% ACTIVE and 49% INACTIVE patients had pain </text>
   <text y="341.055" x="297.26,301.85,304.937,307.826,312.416,315.008,318.599,322.685,327.275,334.367,337.454,342.044,345.131,347.723,350.612,354.698,359.288,363.878,366.767,371.357,375.947,383.534,385.928,392.516,398.609,404.198,407.285,413.873,419.462,422.351,426.437,431.027,435.617,438.506,443.096,447.686,455.273,458.162,461.249,467.837,474.425,480.518,486.107,489.194,495.782,501.371,504.26,508.85,512.936,515.528,518.12,522.206,526.796,529.388,532.889" svgx:width="0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.78,0.33,0.5,0.33,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.33,0.72,0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">or discomfort and 55% ACTIVE and 41% INACTIVE patients </text>
   <text y="352.053" x="297.26,301.346,304.433,307.025,311.111,314.198,316.538,321.128,325.718,328.058,335.15,339.74,344.33,346.922,351.512,355.103" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after 24 months.</text>
   <text y="363.051" x="309.257,317.258,322.262,325.259,328.76,333.26,337.256,341.252,343.754,346.751,349.253,353.249,356.057,359.558,364.058,368.558,371.06,375.056,379.052,381.554,384.056,388.556,392.552,395.36,399.86,404.36,408.356,410.858,413.36,415.862,420.362,423.17,427.67,430.667,433.475,435.977,438.479,441.476,445.472,448.28,450.782,457.784,462.284,466.28,468.782,471.779,478.781,482.777,487.277,489.779,492.587,497.087,501.083,505.079,507.581,510.083,514.583,518.579,523.079,525.887,528.389,532.889" svgx:width="0.89,0.56,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS-specific subjective quality of life impairment declined in </text>
   <text y="374.049" x="297.26,301.76,306.26,308.762,313.262,315.512,316.466,320.966,323.963,328.463,332.963,337.463,340.964,343.214,344.168,348.668,353.168,357.164,360.161,362.411,363.356,367.856,372.356,374.606,375.56,382.562,387.062,391.562,394.064,398.564,402.065,404.315,405.269,409.265,412.766,415.016,415.97,422.972,426.968,430.964,434.465,438.965,441.962,445.958,450.458,452.708,453.653,458.153,462.653,464.903,465.857,468.359,472.859,476.855,479.105,480.059,485.063,491.066,494.063,502.064,508.562,513.566,515.816,516.761,523.259,527.759,532.925" svgx:width="0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.67,0.33,0.89,0.72,0.56,0.25,0.55,0.72,0.5,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">both groups over 24 months as measured by the PRIMUS QoL </text>
   <text y="385.047" x="297.26,301.76,306.26,310.256,313.757,316.259,318.761,323.261,327.761,332.261,336.257,338.759,341.756,345.752,348.002,350.252,353.06,356.057,363.059,367.559,371.555,374.057,377.054,384.056,388.052,392.552,395.054,397.304,400.112,406.61,410.606,414.107,416.357,419.174,422.675,425.177,428.174,432.674,437.174,441.674,445.67,448.667,450.917,453.725,457.721,462.221,466.721,468.971,471.779,476.279,480.275,484.271,486.773,489.275,493.775,497.771,502.271,504.521,507.338,509.84,513.836,517.337,520.838,523.088,525.896,528.398,532.898" svgx:width="0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.25,0.55,0.33,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.33,0.5,0.5,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.44,0.39,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">questionnaire. Impairment was stronger and declined less in </text>
   <text y="396.045" x="297.26,303.758,309.761,315.26,318.257,324.755,330.254,332.639,337.139,341.135,343.637,346.139,350.135,354.635,357.137,360.638,363.023,366.02,372.518,375.02,377.405,381.905,384.155,388.655,397.655,402.155,404.405,408.905,411.155,413.54,416.537,419.039,421.424,425.924,428.174,432.674,441.674,446.174,448.424,452.924,455.921,458.171,460.556,468.557,473.561,476.558,480.059,484.559,488.555,492.551,495.053,498.05,500.552,504.548,506.933,510.434,514.934,519.434,521.936,525.932,529.928" svgx:width="0.72,0.67,0.61,0.33,0.72,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.28,0.25,0.5,0.25,0.5,1.0,0.5,0.25,0.5,0.25,0.25,0.33,0.28,0.25,0.5,0.25,0.5,1.0,0.5,0.25,0.5,0.33,0.25,0.25,0.89,0.56,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ACTIVE patients (A: 8.7→7.8, I: 8.3→6.8). MS-specific subjec-</text>
   <text y="407.043" x="297.26,299.762,302.264,306.764,310.76,312.83,316.826,320.822,323.324,325.826,330.326,332.828,335.33,339.83,341.9,344.402,351.404,355.904,359.9,362.402,365.399,372.401,376.397,380.897,383.399,385.469,387.971,391.967,396.467,400.967,404.963,409.463,411.533,414.035,418.535,420.605,423.107,427.607,431.603,434.6,438.596,442.592,446.093,450.089,452.159,454.661,459.161,461.231,465.731,470.231,472.733,477.233,479.303,483.803,486.8,491.3,495.8,500.3,503.801,505.871,510.371,514.871,518.867,521.864,523.934,528.434,532.934" svgx:width="0.28,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tive activity impairment tended to increase in both groups over 24 </text>
   <text y="418.041" x="297.26,304.262,308.762,313.262,315.764,320.264,323.765,326.015,328.895,332.891,336.392,338.642,341.522,348.524,352.52,356.516,360.017,364.517,367.514,371.51,376.01,378.26,381.14,385.64,390.14,392.39,395.27,397.772,402.272,406.268,408.518,411.398,416.402,422.405,425.402,433.403,439.901,444.905,447.155,450.035,454.031,458.027,460.529,463.031,467.531,470.033,472.535,477.035,479.285,482.165,486.665,491.165,495.161,498.662,501.164,503.666,508.166,512.666,517.166,521.162,523.664,526.661,530.657,532.907" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.67,0.33,0.89,0.72,0.56,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months as measured by the PRIMUS activity questionnaire. </text>
   <text y="429.039" x="297.26,303.758,307.754,310.256,312.758,317.258,319.76,322.262,326.762,329.219,331.721,338.723,343.223,347.219,349.721,352.718,359.72,363.716,368.216,370.718,373.175,379.673,383.669,387.17,389.627,393.128,395.63,398.627,403.127,407.627,412.127,416.123,419.12,421.577,425.573,430.073,434.573,437.03,441.53,445.526,449.522,452.024,454.526,459.026,463.022,467.522,469.979,476.981,481.481,484.478,488.474,490.931,493.433,497.933,499.895,506.393,512.396,517.895,520.892,527.39,532.889" svgx:width="0.72,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.33,0.5,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.25,0.78,0.5,0.33,0.44,0.25,0.28,0.5,0.25,0.72,0.67,0.61,0.33,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Activity impairment was stronger and declined more in ACTIVE </text>
   <text y="440.037" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,325.259,327.509,330.506,337.004,339.506,341.756,346.256,348.506,353.006,362.006,366.506,368.756,373.256,375.506,377.756,380.753,383.255,385.505,390.005,392.255,396.755,405.755,410.255,412.505,417.005,420.002" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.28,0.25,0.5,0.25,0.5,1.0,0.5,0.25,0.5,0.25,0.25,0.33,0.28,0.25,0.5,0.25,0.5,1.0,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients (A: 4.7→5.0, I: 4.0→4.1).</text>
   <text y="451.035" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="451.035" x="348.758,354.761,358.757,361.259,365.255,369.755,373.256,375.758,380.258,384.758,386.747,391.247,395.243,397.745,400.247,404.243,408.743,411.245,414.746,416.735,419.732,423.728,427.724,430.226,432.215,436.715,439.217,442.718,446.219,450.215,452.717,455.219,458.72,461.717,464.219,468.215,472.715,474.965,476.954,480.95,485.45,489.95,491.939,494.441,501.443,505.943,509.939,512.441,515.438,519.434,523.934,525.923,528.425,532.925" svgx:width="0.67,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.28,0.25,0.5,0.28,0.39,0.39,0.44,0.28,0.28,0.39,0.33,0.28,0.44,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Relapsing patients feel dissatisfied, and impaired in </text>
   <text y="462.033" x="297.26,299.762,304.262,308.258,310.508,313.127,317.627,321.623,325.619,328.616,330.866,333.485,336.482,340.982,343.484,345.986,350.486,356.984,359.486,363.986,368.486,370.736,373.355,377.351,379.601,382.22,385.217,389.213,391.715,395.711,400.211,403.712,407.708,409.958,412.208,414.827,419.831,422.333,425.33,429.83,434.33,438.83,441.08,443.699,446.696,450.692,453.194,457.19,461.69,465.191,469.187,471.437,474.056,478.556,481.553,485.549,490.049,494.045,498.545,501.047,503.549,508.049,512.549,514.799,517.418,524.42,528.416,532.916" svgx:width="0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.25,0.55,0.56,0.28,0.33,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the year following a relapse. Strong relapse prevention may </text>
   <text y="473.031" x="297.26,299.762,306.764,311.264,314.261,318.761,323.261,327.257,329.507,334.007,338.003,340.505,343.007,347.003,351.503,354.005,356.255,359.756,363.752,366.254,368.756,372.257,375.254,379.25,383.246,385.748,388.25,392.75,397.25,399.5,401.75,406.25,410.75,414.746,417.248,419.75,422.252,426.752,429.002,433.502,436.499,438.749,441.251,443.753,446.75,450.746,452.996,456.992,461.492,465.992,468.242,472.238,476.234,478.736,481.238,485.738,488.24,490.742,494.657" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improve patient satisfaction, quality of life and activity.</text>
   <text y="504.027" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P792</text>
   <text y="515.025" x="297.26,302.264,306.764,314.261,319.265,322.262,326.762,334.259,337.76,340.01,344.51,349.514,354.518,356.768,361.268,364.769,368.27,372.77,376.766,379.268,383.768,386.765,389.267,393.767,398.771,401.021,407.519,410.021,413.018,418.022,420.272,425.276,429.272,433.772,436.274,439.271,444.275,446.525,451.025,456.029,459.026,463.022,467.522,475.019,479.015,482.516,484.766,487.268,492.272" svgx:width="0.56,0.5,0.83,0.56,0.33,0.5,0.83,0.39,0.25,0.5,0.56,0.56,0.25,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.28,0.5,0.56,0.25,0.72,0.28,0.33,0.56,0.25,0.56,0.44,0.5,0.28,0.33,0.56,0.25,0.5,0.56,0.33,0.44,0.5,0.83,0.44,0.39,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Symptoms and association with health outcomes in </text>
   <text y="526.023" x="297.26,301.256,305.252,307.754,312.254,317.258,320.759,323.261,328.265,332.765,335.762,339.758,343.754,351.251,353.753,356.75,359.747,362.249,367.253,371.753,374.003,381.5,386.504,389.006,392.003,394.505,399.509,402.011,406.007,408.257,411.758,415.754,418.256,422.252,426.248,430.748,434.249,436.751,440.252,443.249,445.499,449.495,453.491,456.992,461.996,464.498,467.495,470.996,473.246,477.746,480.743,482.993,487.493,489.743,496.241,501.245" svgx:width="0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.33,0.44,0.44,0.83,0.28,0.33,0.33,0.28,0.56,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.33,0.25,0.44,0.44,0.39,0.56,0.28,0.33,0.39,0.25,0.5,0.33,0.25,0.5,0.25,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">relapsing-remitting multiple sclerosis: results of a US </text>
   <text y="537.021" x="297.26,302.264,306.764,309.761,312.263,316.259,321.263,324.26,326.51,330.011,335.015,339.011,343.511,347.507" svgx:width="0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.25,0.39,0.56,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">patient survey</text>
   <text y="548.019" x="297.26,303.758,309.257,311.507,320.003,322.505,325.007,327.509,330.011,334.007,341.009" svgx:width="0.72,0.61,0.25,0.94,0.28,0.28,0.28,0.28,0.44,0.78,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AE Williams</text>
   <text y="545.583" x="344.509" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="548.103" x="347.434,349.684,351.934,355.435,360.934,363.184,369.682,372.184,376.18,378.682,381.679" svgx:width="0.25,0.25,0.39,0.61,0.25,0.72,0.28,0.44,0.28,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JT Vietri</text>
   <text y="545.583" x="384.181" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="548.103" x="387.106,389.356,391.606,398.104,400.354,403.351,406.852,411.352,415.348,418.345,424.843,429.343,433.843" svgx:width="0.25,0.25,0.72,0.25,0.33,0.39,0.5,0.44,0.33,0.72,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Isherwood</text>
   <text y="545.583" x="438.342" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="548.103" x="441.267,443.517,445.767,452.265,454.515,459.519,462.021,466.521" svgx:width="0.25,0.25,0.72,0.25,0.56,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Flor</text>
   <text y="545.583" x="469.518" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="556.581" x="297.259" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="559.103" x="300.185,307.682,311.678,316.178,319.175,325.673,332.171,336.671,341.171,345.167,347.417,349.667,355.67,360.17,366.668,371.168,374.669,377.171,381.671,386.171,390.167,392.417,394.667,401.165,405.665,408.167,410.669,414.665,419.165,421.415,427.418,429.92,434.42,438.92,443.42,447.92,454.418,456.668" svgx:width="0.83,0.44,0.5,0.33,0.72,0.72,0.5,0.5,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MedImmune, Cambridge, United Kingdom, </text>
   <text y="556.583" x="458.916" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="559.103" x="461.841,467.844,472.344,476.844,479.346,483.846,487.347,489.597,496.095,500.091,504.591,507.093,509.595,514.095,516.345" svgx:width="0.67,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Kantar Health, </text>
   <text y="570.101" x="297.258,304.755,307.257,309.759,314.259,318.759,321.009,323.259,326.256,328.758,333.258,335.76,339.756,342.006" svgx:width="0.83,0.28,0.28,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Milan, Italy, </text>
   <text y="567.583" x="344.258" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="570.103" x="347.183,353.186,357.686,362.186,364.688,369.188,372.689,374.939,381.437,385.433,389.933,392.435,394.937,399.437,401.687,403.937,409.436,413.936,417.437,421.937,428.435,430.685,432.935,439.433,443.933,446.435,448.937,452.933,457.433,459.683,465.686,468.188,472.688,477.188,481.688,486.188,492.686,494.936" svgx:width="0.67,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.61,0.5,0.39,0.5,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Kantar Health, Epsom, United Kingdom, </text>
   <text y="578.583" x="297.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="581.103" x="300.185,307.682,311.678,316.178,319.175,325.673,332.171,336.671,341.171,345.167,347.417,349.667,356.165,360.665,363.167,365.669,370.169,374.165,377.666,381.167,385.667,390.167,393.668,398.168,400.418,402.668,410.165,416.663,418.913,421.163,427.661,432.161,434.663,437.165,441.161,445.661,447.911,452.411,454.913,459.413,461.915,465.911" svgx:width="0.83,0.44,0.5,0.33,0.72,0.72,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.5,0.44,0.39,0.39,0.5,0.5,0.39,0.5,0.25,0.25,0.83,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MedImmune, Gaithersburg, MD, United States</text>
   <text y="608.103" x="297.26,303.263,307.763,311.759,316.763,321.263,325.097,329.597,334.601,339.605,344.609,347.606" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="608.103" x="349.946,355.949,358.289,362.789,366.785,369.782,372.284,376.28,378.782,383.282,385.622,390.122,393.119,395.459,398.96,403.46,410.462,414.962,417.464,421.964,428.966,432.467,434.807,439.307,443.303,447.803,451.799,454.139,458.639,462.635,466.631,471.131,473.471,476.468,480.464,484.964,489.464,492.461,494.963,498.959,503.459,505.709,508.049,512.549,517.049,519.551,521.891,524.393,528.893,532.889" svgx:width="0.72,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A variety of symptoms have been reported, but the </text>
   <text y="619.101" x="297.26,301.76,304.757,308.753,313.253,317.249,319.751,323.747,328.247,332.243,336.239,338.489,339.272,343.772,346.769,349.019,349.802,353.303,357.803,361.799,365.795,368.297,371.294,373.796,377.792,380.042,380.825,384.326,388.826,395.828,400.328,402.83,407.33,414.332,417.833,420.083,420.866,423.368,427.868,430.118,430.901,433.898,437.894,440.396,444.392,448.892,452.393,454.895,459.395,463.895,466.892,469.889,473.885,480.887,483.389,485.891,488.393,490.895,495.395,499.895,502.145,502.928,509.93,514.43,516.932,519.434,521.936,526.436,528.938,532.934" svgx:width="0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prevalence of specific symptoms in relapsing-remitting multiple </text>
   <text y="630.099" x="297.26,300.761,304.757,307.259,311.255,314.252,318.752,322.253,324.755,328.256,330.911,333.908,339.911,345.914,353.915,358.919,361.916,364.166,366.821,371.321,375.821,382.319,384.974,387.476,391.976,395.972,400.472,403.127,407.123,410.12,414.116,416.771,419.768,423.764,426.266,430.262,432.764,436.76,441.26,443.915,446.417,450.917,453.572,458.072,462.572,466.568,469.223,473.219,477.719,482.219,484.721,489.221,493.217,495.854,498.104,500.759,504.755,509.255,513.755,516.41,518.912,523.412,527.408,529.91,532.907" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.25,0.5,0.5,0.72,0.25,0.28,0.5,0.44,0.5,0.25,0.44,0.33,0.44,0.25,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.5,0.44,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (RRMS), how they are related to one another, and their </text>
   <text y="641.097" x="297.26,299.762,306.764,311.264,315.26,319.256,321.758,324.323,328.823,333.323,335.888,340.388,344.384,348.38,350.882,353.384,357.884,360.449,364.949,369.449,371.951,375.947,380.447,387.449,391.445,394.946,397.511,400.013,403.514,406.079,410.579,415.079,417.581,420.146,426.644,430.64,433.142,435.644,438.209,442.709,447.209,451.709,455.705,458.702,462.203,464.705,469.205,473.705,478.205,480.455,482.858,491.354,495.854,498.356,500.858,504.854,507.419,510.416,514.412,516.914,520.91,525.41,528.911,532.907" svgx:width="0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.28,0.39,0.25,0.5,0.5,0.28,0.25,0.72,0.44,0.28,0.28,0.25,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.94,0.5,0.28,0.28,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">impact on health outcomes is not well understood. While relapse </text>
   <text y="652.095" x="297.26,300.257,304.253,306.755,310.751,312.443,314.945,318.446,320.138,322.64,327.14,331.136,332.828,335.825,339.821,344.321,348.821,351.323,355.319,357.821,362.321,365.318,369.818,371.51,375.506,380.006,384.506,389.006,393.506,396.008,400.508,403.01,404.702,407.699,412.199,415.196,416.888,420.884,425.384,429.884,432.881,437.381,441.881,445.877,448.379,450.071,454.571,457.568,459.26,461.762,466.262,470.258,473.255,477.251,481.751,484.253,488.249,491.75,493.442,496.439,500.939,503.936,505.628,511.631,517.634,525.635,530.639,532.889" svgx:width="0.33,0.44,0.28,0.44,0.25,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.5,0.33,0.25,0.67,0.67,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate is the regulatory endpoint for approval of therapies for RRMS, </text>
   <text y="663.093" x="297.26,301.76,305.756,308.258,310.76,314.756,319.256,321.758,323.657,330.155,334.151,336.653,339.155,342.152,346.652,350.648,353.15,357.65,362.15,364.049,368.045,372.545,377.045,378.944,383.444,387.44,391.436,393.938,396.44,400.94,403.937,406.934,410.93,413.432,417.428,419.93,423.926,428.426,430.325,434.825,439.325,443.321,445.823,448.325,450.827,455.327,457.226,461.726,464.723,466.622,469.124,471.626,474.623,478.619,480.518,483.515,490.013,496.016,502.514,507.014,512.513,515.51,517.409,524.411,528.407,532.907" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.72,0.44,0.28,0.28,0.33,0.5,0.44,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.33,0.72,0.67,0.72,0.5,0.61,0.33,0.25,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patient well-being and health-related quality of life (HRQoL) may </text>
   <text y="674.091" x="297.26,301.76,305.756,307.79,312.29,315.287,319.787,322.784,327.284,331.784,336.284,340.784,343.286,347.786,349.82,353.816,356.651,359.648,363.644,367.64,370.142,374.138,378.638,380.672,385.172,389.672,391.706,395.702,400.202,404.702,408.698,411.695,414.197,418.193,422.693,426.689,430.685,432.719,437.219,440.216,442.25,445.751,450.251,457.253,461.753,464.255,468.755,475.757,479.258,481.292,485.288,489.788,494.288,496.322,500.318,503.819,505.853,509.354,513.854,517.85,522.35,524.384,528.884,532.88" svgx:width="0.5,0.44,0.25,0.5,0.33,0.5,0.33,0.5,0.5,0.5,0.5,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">be profoundly affected by experience of symptoms and as such be </text>
   <text y="685.089" x="297.26,299.762,306.764,311.264,315.764,318.761,321.263,325.259,329.759,332.261,334.511,337.013,341.513,343.763,348.263,352.763,357.263,361.259,364.256,367.757,370.259,374.255,378.755,383.255,385.505,389.501,394.001,398.501,400.751,407.753,411.749,415.745,419.246,423.746,426.743,430.739,432.989,435.491,439.991,442.241,446.237,448.739,451.241,455.741,458.243,462.239,466.235,468.737,470.987,473.489,476.486,478.988,482.984,485.486,488.987" svgx:width="0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">important to understand and measure in clinical trials.</text>
   <text y="696.087" x="297.26,304.262,309.266,312.263,316.259,320.255,323.252,325.754,330.254,334.25,337.751,340.748" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="696.087" x="343.664,348.533,353.033,355.949,360.449,364.445,367.946,371.942,374.939,377.441,381.941,385.937,388.853,393.353,397.853,404.351,407.267,410.768,415.268,422.27,426.77,429.272,433.772,440.774,444.275,447.191,451.691,454.688,457.604,463.607,469.61,477.611,482.615,485.531,489.527,494.027,497.024,501.524,505.52,509.516,514.016,517.013,519.929,523.925,528.425,532.925" svgx:width="0.61,0.5,0.25,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.25,0.5,0.5,0.72,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.33,0.25,0.67,0.67,0.89,0.56,0.25,0.44,0.5,0.33,0.5,0.44,0.44,0.5,0.33,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To describe how symptoms of RRMS co-occur and </text>
   <text y="707.085" x="297.26,299.762,304.262,308.258,310.76,313.757,316.007,318.509,325.511,330.011,334.007,338.003,340.505,342.755,347.255,351.755,354.005,358.505,362.501,365.003,367.505,371.501,376.001,378.503,381.5,384.497,388.493,392.993,397.493,400.49,402.992,406.988,411.488,413.738,418.238,422.738,425.24,429.236,433.736,440.738,444.734,448.235" svgx:width="0.28,0.5,0.44,0.28,0.33,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">their impact on patient-reported outcomes.</text>
   <text y="718.083" x="297.26,305.756,309.752,312.749,317.753,322.253,327.257,330.758,333.755" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="718.083" x="338.498,341.495,345.995,350.495,352.997,357.497,359.999,364.499,368.999,372.995,375.497,378.998,381.248,383.741,390.239,394.739,399.239,401.489,403.982,406.979,410.975,415.475,419.975,422.972,425.474,429.47,433.97,436.22,438.713,442.709,444.959,447.452,451.952,456.452,460.952,464.453,466.955,470.951,473.453,477.449,481.949,484.199,486.692,491.192,493.694,497.69,502.19,506.69,511.19,514.691,517.193,520.694,522.944,525.437,529.937,532.934" svgx:width="0.33,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Individuals who reported a physician diagnosis of </text>
   <text y="729.081" x="297.26,303.263,309.266,317.267,322.271,324.521,326.807,329.309,333.809,336.059,338.345,342.341,344.591,346.877,349.379,353.375,356.21,360.71,364.706,366.956,369.242,373.742,377.738,382.238,386.234,389.231,393.227,395.729,397.979,400.265,404.765,408.761,412.757,415.259,417.761,422.261,424.511,426.797,430.298,434.798,437.795,442.295,446.291,450.791,453.041,455.327,457.829,462.329,464.579,466.865,469.367,473.867,477.863,480.113,482.399,488.897,493.397,495.899,498.401,502.397,506.897,509.147,511.433,516.437,518.939,522.935,525.437,529.433,532.934" svgx:width="0.67,0.67,0.89,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.56,0.28,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RRMS in a large general health survey in the United States </text>
  </g>
 </g>
</svg>
